AN UNBIASED VIEW OF JNJ-632

Treatment method with SR18662 considerably lessens expansion and proliferation of CRC cells. SR18662 reveals enhanced efficacy in cutting down viability of many CRC mobile strains. Movement cytometry Investigation pursuing SR18662 cure exhibits a rise in cells captured in both S or G2/M phases of the cell cycle and an important rise in the quantity